TASCOM Co.,Ltd. (XKON:336040)
South Korea
· Delayed Price · Currency is KRW 4,100.00
-100.00 (-2.38%)
At close: Mar 9, 2026
TASCOM Company Description
TASCOM Co.,Ltd. engages in the research and development, manufacturing, and sales of in vitro diagnostic medical devices.
The company offers SimplexTAS, an in vitro diagnostic medical device for point-of-care diagnosis that can diagnose and monitor various diseases, such as diabetes, hyperlipidemia, liver disease, kidney disease, and infections.
It also provides pen needles and syringes. The company was formerly known as YIDOBIO Inc. and changed its name to TASCOM Co.,Ltd. in September 2021.
TASCOM Co.,Ltd. was founded in 2014 and is headquartered in Anyang-Si, South Korea.
TASCOM Co.,Ltd.
| Country | South Korea |
| Founded | 2014 |
| Industry | Surgical and Medical Instruments and Apparatus |
| CEO | InGeun Lee |
Contact Details
Address: 268, 824, Hagui-ro, Dongan-gu, Anyang-Si South Korea | |
| Phone | 82 3 1433 6620 |
| Website | yidobio.com |
Stock Details
| Ticker Symbol | 336040 |
| Exchange | Korea New Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| InGeun Lee | Chief Executive Officer |